KRAS and lung adenocarcinoma: An earlier report suggests that PKCλ activates NOTCH3 expression via ELF3 phosphorylation, and this axis maintains the highly tumorigenic TIC phenotype in KRAS-mediated lung adenocarcinoma [49].